Suppr超能文献

最近感染性心内膜炎研究结果表明,对于患有二叶式主动脉瓣或二尖瓣脱垂的患者,牙医应开具预防性抗生素。

Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse.

机构信息

Department of Dentistry, School of Medicine and Life Sciences Pontifícia Universidade Católica do Paraná Imaculada Conceição Street, 1155, Prado Velho, Curitiba Zip Code: 80215-901, Paraná, Brazil

出版信息

Med Oral Patol Oral Cir Bucal. 2023 Nov 1;28(6):e567-e571. doi: 10.4317/medoral.25984.

Abstract

BACKGROUND

The scientific validity of the European Society of Cardiology's (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at "high risk" of adverse events when undergoing high risk dental procedures (HRDP) is unclear.

MATERIAL AND METHODS

A systematic review of studies conducted between 2017 and 2022 and catalogued in the PubMed database was undertaken to ascertain if this edict was associated with changes in IE incidence, development of infection in unprotected cardiac anomalies, developing infection and resultant adverse clinical outcomes.

RESULTS

Retrieved were 19 published manuscripts, however of these, 16 were excluded because they did not bare upon the issues of concern. Among the three studies eligible for review were those in the Netherlands, Spain, and England. The results of the Dutch study denoted a significant increase in the incidence of IE cases over the projected historical trend (rate ratio: 1327, 95% CI 1.205-1.462; p<0.001) after the introduction of the ESC guidelines. The findings from the Spanish study evidenced the uniquely high in-hospital IE associated fatality rates suffered by patients having bicuspid aortic valves (BAV); 5.6% or mitral valve prolapse (MVP); 10%. The British study provided evidence that the incidence of fatal IE infection was significantly greater among an "intermediate risk" cohort of patients, (a group likely including those with BAC and MVP for which the ESC guidelines don't recommend AP), than among "high risk" patients (P = 0.002).

CONCLUSIONS

Patients having either a BAV or MVP are at significant risk of developing IE and suffering serious sequelae including death. The ESC guidelines must reclassify these specific cardiac anomalies into the "high risk" category so that AP are recognized as being needed prior to provision of HRDP.

摘要

背景

欧洲心脏病学会(ESC)感染性心内膜炎(IE)指南的科学性受到质疑,该指南将预防性抗生素(AP)的应用仅限于心脏异常(如人工瓣膜)患者,认为这些患者在接受高风险牙科操作(HRDP)时发生不良事件的风险“高”。

材料和方法

系统检索了 2017 年至 2022 年期间在 PubMed 数据库中进行的研究,并确定该规定是否与 IE 发病率的变化、无保护心脏异常患者感染的发生、感染的发生和由此产生的不良临床结局有关。

结果

共检索到 19 篇已发表的文献,但其中 16 篇因与关注问题无关而被排除。在符合审查条件的三项研究中,有两项来自荷兰、西班牙和英国。荷兰研究的结果表明,在 ESC 指南出台后,IE 病例的发病率显著高于预测的历史趋势(率比:1327,95%CI 1.205-1.462;p<0.001)。西班牙研究的结果表明,二叶式主动脉瓣(BAV)患者的住院 IE 相关死亡率非常高,为 5.6%;二尖瓣脱垂(MVP)患者为 10%。英国的研究表明,在“中危”患者(该组可能包括 ESC 指南不建议使用 AP 的 BAC 和 MVP 患者)中,致命性 IE 感染的发生率明显高于“高危”患者(P=0.002)。

结论

患有 BAV 或 MVP 的患者发生 IE 并出现严重后果(包括死亡)的风险显著增加。ESC 指南必须将这些特定的心脏异常重新归类为“高危”类别,以便在提供 HRDP 之前认识到需要使用 AP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21b1/10635622/d4724f5e9f1b/medoral-28-e567-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验